共有 50 笔近期内部人交易记录记录，涉及 Cogent Biosciences, Inc. (COGT), 包括 41 笔买入 和 9 笔卖出. 内部人买入总额为 $64.89M 内部人卖出总额为 $139.58M.
近期活跃的重要内部人包括 Ferrante Karen Jean, Fairmount Funds Management Llc, Green John L.. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — COGT
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-04-01 |
Ferrante Karen Jean |
Director |
限制性股票授予 (RSU) |
686 |
$35.24 |
$24.17K |
686 |
| 2026-03-31 |
Fairmount Funds Management Llc |
Director |
转换（卖出） |
28,000 |
- |
- |
39,414 |
| 2026-01-22 |
Fairmount Funds Management Llc |
Director |
知情卖出 |
3,500,000 |
$36.40 |
$127.4M |
5,503,418 |
| 2026-01-01 |
Ferrante Karen Jean |
Director |
限制性股票授予 (RSU) |
643 |
$34.74 |
$22.34K |
643 |
| 2025-12-26 |
Green John L. |
Chief Financial Officer |
知情卖出 |
77,000 |
$38.68 |
$2.98M |
131,834 |
| 2025-12-26 |
Kearns Evan |
Chief Legal Officer |
知情卖出 |
65,000 |
$38.70 |
$2.52M |
109,398 |
| 2025-12-26 |
Sachs Jessica |
Chief Medical Officer |
知情卖出 |
82,642 |
$38.70 |
$3.2M |
133,938 |
| 2025-12-26 |
Robinson John Edward |
Chief Scientific Officer |
知情卖出 |
90,000 |
$38.74 |
$3.49M |
140,002 |
| 2025-12-17 |
Robbins Andrew R |
President and CEO |
限制性股票授予 (RSU) |
185,000 |
- |
- |
185,000 |
| 2025-12-17 |
Green John L. |
Chief Financial Officer |
限制性股票授予 (RSU) |
50,000 |
- |
- |
53,841 |
| 2025-12-17 |
Kearns Evan |
Chief Legal Officer |
限制性股票授予 (RSU) |
40,000 |
- |
- |
40,000 |
| 2025-12-17 |
Sachs Jessica |
Chief Medical Officer |
限制性股票授予 (RSU) |
50,000 |
- |
- |
51,296 |
| 2025-12-17 |
Robinson John Edward |
Chief Scientific Officer |
限制性股票授予 (RSU) |
50,000 |
- |
- |
50,000 |
| 2025-12-17 |
Pinnow Cole |
Chief Commercial Officer |
限制性股票授予 (RSU) |
65,000 |
$39.45 |
$2.56M |
65,000 |
| 2025-10-01 |
Ferrante Karen Jean |
Director |
限制性股票授予 (RSU) |
1,642 |
$14.13 |
$23.2K |
1,642 |
| 2025-07-10 |
Fairmount Funds Management Llc |
Director |
知情买入 |
2,777,777 |
$9.00 |
$25M |
9,003,418 |
| 2025-07-01 |
Ferrante Karen Jean |
Director |
限制性股票授予 (RSU) |
3,314 |
$7.22 |
$23.93K |
3,314 |
| 2025-06-04 |
Morris Arlene |
Director |
限制性股票授予 (RSU) |
44,700 |
$5.64 |
$252.11K |
44,700 |
| 2025-06-04 |
Ferrante Karen Jean |
Director |
限制性股票授予 (RSU) |
44,700 |
$5.64 |
$252.11K |
44,700 |
| 2025-06-04 |
Harwin Peter Evan |
Director |
限制性股票授予 (RSU) |
44,700 |
$5.64 |
$252.11K |
44,700 |
| 2025-06-04 |
Ros Matthew |
Director |
限制性股票授予 (RSU) |
44,700 |
$5.64 |
$252.11K |
44,700 |
| 2025-06-04 |
Shegog Todd |
Director |
限制性股票授予 (RSU) |
44,700 |
$5.64 |
$252.11K |
44,700 |
| 2025-06-04 |
Cain Christopher W. |
Director |
限制性股票授予 (RSU) |
44,700 |
$5.64 |
$252.11K |
44,700 |
| 2025-04-01 |
Ferrante Karen Jean |
Director |
限制性股票授予 (RSU) |
3,788 |
$5.79 |
$21.93K |
3,788 |
| 2025-01-23 |
Robbins Andrew R |
President and CEO |
限制性股票授予 (RSU) |
915,000 |
$8.89 |
$8.13M |
915,000 |
| 2025-01-23 |
Green John L. |
Chief Financial Officer |
限制性股票授予 (RSU) |
270,000 |
$8.89 |
$2.4M |
270,000 |
| 2025-01-23 |
Kearns Evan |
Chief Legal Officer |
限制性股票授予 (RSU) |
230,000 |
$8.89 |
$2.04M |
230,000 |
| 2025-01-23 |
Sachs Jessica |
Chief Medical Officer |
限制性股票授予 (RSU) |
270,000 |
$8.89 |
$2.4M |
270,000 |
| 2025-01-23 |
Robinson John Edward |
Chief Scientific Officer |
限制性股票授予 (RSU) |
270,000 |
$8.89 |
$2.4M |
270,000 |
| 2025-01-23 |
Pinnow Cole |
Chief Commercial Officer |
限制性股票授予 (RSU) |
240,000 |
$8.89 |
$2.13M |
240,000 |
| 2025-01-14 |
Pinnow Cole |
Chief Commercial Officer |
知情买入 |
43,750 |
$7.60 |
$332.41K |
45,848 |
| 2025-01-01 |
Ferrante Karen Jean |
Director |
限制性股票授予 (RSU) |
2,785 |
$7.80 |
$21.72K |
2,785 |
| 2024-10-01 |
Ferrante Karen Jean |
Director |
限制性股票授予 (RSU) |
2,034 |
$10.75 |
$21.87K |
2,034 |
| 2024-07-01 |
Ferrante Karen Jean |
Director |
限制性股票授予 (RSU) |
2,462 |
$8.94 |
$22.01K |
2,462 |
| 2024-06-10 |
Fairmount Funds Management Llc |
Director |
期权行权（卖出） |
1,500 |
- |
- |
- |
| 2024-06-05 |
Morris Arlene |
Director |
限制性股票授予 (RSU) |
44,700 |
$8.92 |
$398.72K |
44,700 |
| 2024-06-05 |
Ferrante Karen Jean |
Director |
限制性股票授予 (RSU) |
44,700 |
$8.92 |
$398.72K |
44,700 |
| 2024-06-05 |
Harwin Peter Evan |
Director |
限制性股票授予 (RSU) |
44,700 |
$8.92 |
$398.72K |
44,700 |
| 2024-06-05 |
Ros Matthew |
Director |
限制性股票授予 (RSU) |
44,700 |
$8.92 |
$398.72K |
44,700 |
| 2024-06-05 |
Shegog Todd |
Director |
限制性股票授予 (RSU) |
44,700 |
$8.92 |
$398.72K |
44,700 |
| 2024-06-05 |
Cain Christopher W. |
Director |
限制性股票授予 (RSU) |
44,700 |
$8.92 |
$398.72K |
44,700 |
| 2024-05-25 |
Pinnow Cole |
Chief Commercial Officer |
处置 |
- |
- |
- |
700 |
| 2024-05-25 |
Pinnow Cole |
Chief Commercial Officer |
限制性股票授予 (RSU) |
525,000 |
$8.22 |
$4.32M |
525,000 |
| 2024-04-01 |
Ferrante Karen Jean |
Director |
限制性股票授予 (RSU) |
3,213 |
$6.90 |
$22.17K |
3,213 |
| 2024-03-28 |
Fairmount Funds Management Llc |
Director |
其他（卖出） |
11,914 |
- |
- |
- |
| 2024-02-16 |
Fairmount Funds Management Llc |
10 Percent Owner |
限制性股票授予 (RSU) |
1,500 |
- |
- |
1,500 |
| 2024-01-23 |
Robbins Andrew R |
President and CEO |
限制性股票授予 (RSU) |
1,100,000 |
$4.63 |
$5.09M |
1,100,000 |
| 2024-01-23 |
Green John L. |
Chief Financial Officer |
限制性股票授予 (RSU) |
300,000 |
$4.63 |
$1.39M |
300,000 |
| 2024-01-23 |
Kearns Evan |
Chief Legal Officer |
限制性股票授予 (RSU) |
255,000 |
$4.63 |
$1.18M |
255,000 |
| 2024-01-23 |
Sachs Jessica |
Chief Medical Officer |
限制性股票授予 (RSU) |
300,000 |
$4.63 |
$1.39M |
300,000 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
